ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
119.929,95
0,25%
S&P 500
5.487,03
0,25%
US Dollar vs BRL
5,4556
0,26%
Bitcoin
64.861,70
-0,43%
Brent Oil
84,695
-0,11%
Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. (MM) (PCYC)

  7. (MM) (PCYC) Notícias

PCYC

(MM) (PCYC)

(MM)
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:PCYC
DataHoraFonteTítuloCódigoCompanhia
15/06/201516:02Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:PCYC(MM)
10/06/201513:51Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PCYC(MM)
05/06/201508:01Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:PCYC(MM)
01/06/201512:24Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:PCYC(MM)
31/05/201510:05PR Newswire (US)Ibrutinib (IMBRUVICA®) Phase Ib/II Data Show Promise in Patients with Chronic Graft-Versus-Host-DiseaseNASDAQ:PCYC(MM)
30/05/201508:31PR Newswire (US)Phase III HELIOS Study Results Show Ibrutinib (IMBRUVICA®) Combination Therapy Significantly Increased Progression-Free Surv...NASDAQ:PCYC(MM)
28/05/201520:26Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PCYC(MM)
28/05/201510:00PR Newswire (US)Ibrutinib (IMBRUVICA®) in Combination with Anti-PD-L1 Antibody (MEDI4736) Study Commences for Patients with Two Relapsed/Ref...NASDAQ:PCYC(MM)
26/05/201509:48Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PCYC(MM)
26/05/201509:48Edgar (US Regulatory)(25-NSE)NASDAQ:PCYC(MM)
26/05/201509:40Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:PCYC(MM)
26/05/201508:35Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:PCYC(MM)
26/05/201508:10Edgar (US Regulatory)Post-effective Amendment to an Automatic Shelf Registration of Form S-3asr or Form F-3asr (posasr)NASDAQ:PCYC(MM)
22/05/201509:04PR Newswire (US)European Medicines Agency Issues Positive Opinion, Recommends Full Approval of IMBRUVICA® (ibrutinib) to Treat Waldenstrom's...NASDAQ:PCYC(MM)
20/05/201511:06The Motley FoolSWOT Analysis of Gilead Sciences Inc. StockNASDAQ:PCYC(MM)
14/05/201509:58Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:PCYC(MM)
13/05/201518:21PR Newswire (US)New ibrutinib (IMBRUVICA®) Data to be Showcased at American Society of Clinical Oncology (ASCO) Annual MeetingNASDAQ:PCYC(MM)
05/05/201518:56Dow Jones NewsAbbVie Wraps Up Large Debt Sale for Pharmacyclics DealNASDAQ:PCYC(MM)
05/05/201518:38Dow Jones NewsAbbVie Wraps Up Large Debt Sale For Pharmacyclics DealNASDAQ:PCYC(MM)
05/05/201515:40Dow Jones NewsAbbVie Launches Large Debt Sale for Pharmacyclics DealNASDAQ:PCYC(MM)
05/05/201510:38Analyst Ratings NetworkZacks Lowers Pharmacyclics to Hold (PCYC)NASDAQ:PCYC(MM)
04/05/201518:09Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:PCYC(MM)
04/05/201511:27Analyst Ratings NetworkPharmacyclics Lifted to "Buy" at Zacks (PCYC)NASDAQ:PCYC(MM)
01/05/201519:58Dow Jones NewsAbbVie Extends Exchange Offer to Acquire PharmacyclicsNASDAQ:PCYC(MM)
01/05/201510:15PR Newswire (US)Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business UpdatesNASDAQ:PCYC(MM)
23/04/201515:44Dow Jones NewsAbbVie Profit Rises on Broad Sales Growth -- UpdateNASDAQ:PCYC(MM)
23/04/201514:12Dow Jones NewsAbbVie Profit Rises 4.3%NASDAQ:PCYC(MM)
23/04/201514:08Dow Jones NewsAbbVie Profit Rises 4.3% on Broad Sales GrowthNASDAQ:PCYC(MM)
23/04/201512:34The Motley FoolHumira Propels AbbVie Inc. to a Solid First QuarterNASDAQ:PCYC(MM)
20/04/201513:16Analyst Ratings NetworkBMO Capital Markets Reiterates "Positive" Rating for Pharmacyclics (PCYC)NASDAQ:PCYC(MM)
 Apresentando as notícias mais relevantes sobre:NASDAQ:PCYC

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
HAGA3
HAGA ON
BOV
AZEV4
AZEVEDO PN
BOV
COGN3
COGNA ON
BOV
HBOR3
HELBOR ON
BOV
SGPS3
SPRINGS ON
BOV
FNAM11
Fundo Invest Amazonia Fi...
BOV
PRIO3
PETRORIO ON
BOV
TELB4
TELEBRAS PN
BOV
PCAR3
PÃO DE AÇUCAR ON
BOV
OIBR3
OI ON
BOV
HOOT4
HOTEIS OTHON PN
BOV
VIVR3
VIVER ON
BOV
TECN3
TECHNOS ON
BOV
SHOW3
TIME FOR FUN ON
BOV
DASA3
DASA ON
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados